Yafen Li

1.9k total citations
86 papers, 1.2k citations indexed

About

Yafen Li is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Yafen Li has authored 86 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 41 papers in Cancer Research and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Yafen Li's work include Breast Cancer Treatment Studies (34 papers), HER2/EGFR in Cancer Research (23 papers) and Breast Lesions and Carcinomas (13 papers). Yafen Li is often cited by papers focused on Breast Cancer Treatment Studies (34 papers), HER2/EGFR in Cancer Research (23 papers) and Breast Lesions and Carcinomas (13 papers). Yafen Li collaborates with scholars based in China, United States and Hong Kong. Yafen Li's co-authors include Weiguo Chen, Kunwei Shen, Xiaosong Chen, Ou Huang, Jiayi Wu, Li Zhu, Jianrong He, Xiaochun Fei, Yaoqin Xie and Wen Li and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Yafen Li

79 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yafen Li China 22 402 389 235 183 178 86 1.2k
Zhuwen Wang China 22 278 0.7× 670 1.7× 68 0.3× 1.1k 6.1× 147 0.8× 81 1.9k
Yun Wang China 22 219 0.5× 237 0.6× 776 3.3× 329 1.8× 92 0.5× 112 1.9k
Marie Pennanen United States 13 233 0.6× 390 1.0× 681 2.9× 376 2.1× 182 1.0× 18 1.8k
Shuqian Wang China 24 353 0.9× 271 0.7× 47 0.2× 367 2.0× 49 0.3× 50 1.6k
Xi Zhang China 21 282 0.7× 143 0.4× 108 0.5× 415 2.3× 84 0.5× 185 1.7k
Pengtao Yang China 26 263 0.7× 298 0.8× 44 0.2× 439 2.4× 71 0.4× 81 2.5k
K. Wang China 18 197 0.5× 138 0.4× 68 0.3× 313 1.7× 55 0.3× 141 1.3k
Hyung Seok Park South Korea 34 1.5k 3.7× 1.6k 4.0× 283 1.2× 489 2.7× 858 4.8× 204 3.9k
Zhifeng Chen China 18 101 0.3× 87 0.2× 215 0.9× 213 1.2× 38 0.2× 101 951
Jincai Chang China 11 166 0.4× 63 0.2× 112 0.5× 53 0.3× 45 0.3× 50 1.0k

Countries citing papers authored by Yafen Li

Since Specialization
Citations

This map shows the geographic impact of Yafen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yafen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yafen Li more than expected).

Fields of papers citing papers by Yafen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yafen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yafen Li. The network helps show where Yafen Li may publish in the future.

Co-authorship network of co-authors of Yafen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yafen Li. A scholar is included among the top collaborators of Yafen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yafen Li. Yafen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Yafen, et al.. (2025). A comprehensive model combining radiomics and risk factors for predicting massive hemorrhage in cesarean scar pregnancy during dilatation and curettage. European Journal of Radiology Open. 14. 100661–100661. 1 indexed citations
3.
4.
Chen, Xiaosong, Jiahui Huang, Yiwei Tong, et al.. (2024). Trastuzumab, pertuzumab and nab-paclitaxel plus pyrotinib or not in neoadjuvant treatment of HER2-positive breast cancer: A multi-center, randomized, open-label, phase II study.. Journal of Clinical Oncology. 42(16_suppl). e12634–e12634.
5.
Wang, Tian, Fengtao You, Tingting Zhang, et al.. (2023). B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemia. European journal of medical research. 28(1). 129–129. 8 indexed citations
6.
Li, Yafen, et al.. (2023). Clinical feasibility of MRI-based synthetic CT imaging in the diagnosis of lumbar disc herniation: a comparative study. Acta Radiologica. 65(1). 41–48. 4 indexed citations
7.
Chen, Weilin, Jiayi Wu, Yifei Zhu, et al.. (2023). Impact of clinicopathological factors on extended endocrine therapy decision making in estrogen receptor–positive breast cancer. Frontiers in Oncology. 12. 996522–996522.
8.
Li, Shuai, Jiayi Wu, Ou Huang, et al.. (2022). Association of Molecular Biomarker Heterogeneity With Treatment Pattern and Disease Outcomes in Multifocal or Multicentric Breast Cancer. Frontiers in Oncology. 12. 833093–833093. 6 indexed citations
9.
Li, Shuai, Jiayi Wu, Ou Huang, et al.. (2021). Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients. BMC Cancer. 21(1). 807–807. 1 indexed citations
10.
Chen, Mengdi, Jiayi Wu, Weilin Chen, et al.. (2021). Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast Cancer. Clinical Breast Cancer. 22(2). e147–e156. 3 indexed citations
11.
Li, Yafen, R. Lambo, Wenjian Qin, et al.. (2021). Artificial intelligence-based bone-enhanced magnetic resonance image—a computed tomography/magnetic resonance image composite image modality in nasopharyngeal carcinoma radiotherapy. Quantitative Imaging in Medicine and Surgery. 11(12). 4709–4720. 9 indexed citations
12.
13.
Tong, Yiwei, Jiayi Wu, Ou Huang, et al.. (2020). IGF-1 Interacted With Obesity in Prognosis Prediction in HER2-Positive Breast Cancer Patients. Frontiers in Oncology. 10. 550–550. 14 indexed citations
14.
Hong, Jin, Xiaosong Chen, Weiqi Gao, et al.. (2019). <p>A high absolute lymphocyte count predicts a poor prognosis in HER-2- positive breast cancer patients treated with trastuzumab</p>. Cancer Management and Research. Volume 11. 3371–3379. 14 indexed citations
15.
Chen, Xiaosong, Xiaochun Fei, David Garfield, et al.. (2015). Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients. BMC Cancer. 15(1). 822–822. 26 indexed citations
16.
Li, Yafen. (2013). Research on short-term load forecasting methods of electric buses charging station. Power System Protection and Control. 10 indexed citations
17.
Shen, Kunwei, et al.. (2013). The accuracy of preoperatively predicting axillary lymph node status in breast cancer patients by ultrasonography and MRI. Zhonghua putong waike zazhi. 28(4). 259–262. 2 indexed citations
18.
Du, Ning & Yafen Li. (2013). Automated identification of diabetic retinopathy stages using support vector machine. Chinese Control Conference. 3882–3886. 19 indexed citations
19.
Chen, Xiaosong, Long Sun, Yan Mao, et al.. (2013). Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer. BMC Cancer. 13(1). 390–390. 50 indexed citations
20.
Wei, Min, Li Zhu, Yafen Li, et al.. (2011). Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model. Cancer Science. 102(8). 1537–1544. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuwen Wang Breakdown of academic impact, for papers by Yun Wang Breakdown of academic impact, for papers by Marie Pennanen Breakdown of academic impact, for papers by Shuqian Wang Breakdown of academic impact, for papers by Xi Zhang Breakdown of academic impact, for papers by Pengtao Yang Breakdown of academic impact, for papers by K. Wang Breakdown of academic impact, for papers by Hyung Seok Park Breakdown of academic impact, for papers by Zhifeng Chen Breakdown of academic impact, for papers by Jincai Chang
Rankless by CCL
2026